# FDA Inspection 746821 - Piedmont Reproductive Endocrinology Group, PA - September 27, 2011

Source: https://www.globalkeysolutions.net/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/bde17d52-dacf-48fd-8375-5ab2d33b6782
Source feed: FDA_Inspections

> FDA Inspection 746821 for Piedmont Reproductive Endocrinology Group, PA on September 27, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 746821
- Company Name: Piedmont Reproductive Endocrinology Group, PA
- Inspection Date: 2011-09-27
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1052038 - 2018-04-11](https://www.globalkeysolutions.net/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/ccb3fca0-0b22-4092-9840-0d1f45fe017c)

Company: https://www.globalkeysolutions.net/companies/piedmont-reproductive-endocrinology-group-pa/6e9ebf04-d9fe-4c32-8dbf-471bb002ebe1

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d